Background: Pancreatic cancer is one of the most lethal malignant tumors which
remains a rampant killer across the globe.
Lack of early diagnosis and toxic drugs have failed to
improve the survival rate of pancreatic cancer patients, thus new agents that are safe, available
and effective are urgently needed.